federal_register: 05-3593
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05-3593 | Draft Guidance for Industry: Manufacturing Biological Drug Substances, Intermediates, or Products Using Spore-Forming Microorganisms; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled "Guidance for Industry: Manufacturing Biological Drug Substances, Intermediates, or Products Using Spore-Forming Microorganisms" dated February 2005. The draft document is intended to provide guidance to manufacturers using spore- forming microorganisms in the production of certain biological products. The draft guidance document provides recommendations to industry in response to changes made to the requirements for spore- forming microorganisms to allow greater flexibility in manufacturing. | 2005-02-24 | 2005 | 2 | https://www.federalregister.gov/documents/2005/02/24/05-3593/draft-guidance-for-industry-manufacturing-biological-drug-substances-intermediates-or-products-using | https://www.govinfo.gov/content/pkg/FR-2005-02-24/pdf/05-3593.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled "Guidance for Industry: Manufacturing Biological Drug Substances, Intermediates, or Products Using Spore-Forming Microorganisms" dated February 2005. The... |